Literature DB >> 12599077

Intrahost sequence variation in the streptococcal inhibitor of complement gene in patients with human pharyngitis.

Masakado Matsumoto1, Nancy P Hoe, Mengyao Liu, Stephen B Beres, Gail L Sylva, Claudia M Brandt, Gerhard Haase, James M Musser.   

Abstract

Selection of new variants of the streptococcal inhibitor of complement protein has been implicated in the perpetuation of epidemics caused by serotype M1 strains of group A Streptococcus (GAS). The frequency at which new streptococcal inhibitor of complement (Sic) variants arise in an infected individual is not known. To study this issue, the sic gene was sequenced in 100 isolates cultured from throat swabs of each of 20 patients with acute pharyngitis caused by serotype M1 GAS. Five patients were infected with GAS populations expressing 2 Sic variants characterized by deletion of a region of the protein. In contrast, no intrahost variation was detected in the number of a pentanucleotide repeat (CAAAA) that controls production of a bacterial cell-surface collagen-like protein by slipped-strand mispairing. Sic variation occurs at a sufficient frequency in vivo to result in mixed infections on the mucosal surface of human hosts, potentially contributing to pathogen survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12599077     DOI: 10.1086/367993

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Genomic Landscape of Intrahost Variation in Group A Streptococcus: Repeated and Abundant Mutational Inactivation of the fabT Gene Encoding a Regulator of Fatty Acid Synthesis.

Authors:  Jesus M Eraso; Randall J Olsen; Stephen B Beres; Priyanka Kachroo; Adeline R Porter; Waleed Nasser; Paul E Bernard; Frank R DeLeo; James M Musser
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

2.  Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx.

Authors:  Samuel A Shelburne; Paul Sumby; Izabela Sitkiewicz; Nnaja Okorafor; Chanel Granville; Payal Patel; Jovanka Voyich; Richard Hull; Frank R DeLeo; James M Musser
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Virulence gene pool detected in bovine group C Streptococcus dysgalactiae subsp. dysgalactiae isolates by use of a group A S. pyogenes virulence microarray.

Authors:  Márcia G Rato; Andreas Nerlich; René Bergmann; Ricardo Bexiga; Sandro F Nunes; Cristina L Vilela; Ilda Santos-Sanches; Gursharan S Chhatwal
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

4.  Distribution of phage-associated virulence genes in pharyngeal group a streptococcal strains isolated in Italy.

Authors:  Luca Agostino Vitali; Stefania D'Ercole; Dezemona Petrelli; Maria Chiara Di Luca; Silvia Rombini; Manuela Prenna; Sandro Ripa
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

5.  Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections.

Authors:  Stephen B Beres; Gail L Sylva; Daniel E Sturdevant; Chanel N Granville; Mengyao Liu; Stacy M Ricklefs; Adeline R Whitney; Larye D Parkins; Nancy P Hoe; Gerald J Adams; Donald E Low; Frank R DeLeo; Allison McGeer; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

6.  Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes.

Authors:  Claire E Turner; Matthew Dryden; Matthew T G Holden; Frances J Davies; Richard A Lawrenson; Leili Farzaneh; Stephen D Bentley; Androulla Efstratiou; Shiranee Sriskandan
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

7.  New Insights on Streptococcus dysgalactiae subsp. dysgalactiae Isolates.

Authors:  Cinthia Alves-Barroco; João Caço; Catarina Roma-Rodrigues; Alexandra R Fernandes; Ricardo Bexiga; Manuela Oliveira; Lélia Chambel; Rogério Tenreiro; Rosario Mato; Ilda Santos-Sanches
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.